Breast cancer luminal subtypes, characterized by the positive expression of estrogen receptor (ER) and progesterone receptor (PR), often show a well to moderately differentiated phenotype, a low cellular proliferation index, and are associated with a relatively good survival probability. The gene discussed is PGR; the disease is breast cancer.